Intercept Pharmaceuticals shares are trading higher after Alfasigma announced it will acquire the company for $19 per share in cash.
Portfolio Pulse from Benzinga Newsdesk
Intercept Pharmaceuticals is set to be acquired by Alfasigma for $19 per share in cash. This has resulted in a surge in Intercept's share price.
September 26, 2023 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Intercept Pharmaceuticals' stock price is trading higher following the announcement of its acquisition by Alfasigma for $19 per share in cash.
The acquisition announcement by Alfasigma has led to a surge in Intercept Pharmaceuticals' stock price. Investors are reacting positively to the news, leading to an increase in demand for the company's shares and subsequently driving up the price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100